Literature DB >> 24936484

Generator and lead-related complications of implantable cardioverter defibrillators.

Ahmad Yaminisharif1, Nader Soofizadeh1, Akbar Shafiee1, Ali Kazemisaeid1, Arash Jalali1, Ali Vasheghani-Farahani1.   

Abstract

BACKGROUND: Increase in the number of patients treated with Implantable Cardioverter Defibrillator (ICD) requests more attention regarding its complications.
OBJECTIVES: This study aimed to assess the generator- and lead-related complications at implantation and during follow-up in the patients who were treated with ICD for primary and secondary prevention reasons.
METHODS: We retrospectively reviewed 255 consecutive patients who underwent transvenous ICD implantation for the first time in a 7-year period and were followed-up for 3 years at Tehran Heart Center. The personal and clinical data of the patients as well as specific data on the ICD implantation were retrieved. The frequency of each of the complications was reported and the study variables were compared between the patients with and without complications using Student's t-test and chi-square test where appropriate. P values less than 0.05 were considered as statistically significant.
RESULTS: Out of a total of 525 implanted leads and 255 implanted devices in 255 patients (mean age = 62.57 ± 13.50 years; male = 196 [76.9%]), complications leading to generator or lead replacement occurred in 32 patients (12.5%). The results revealed no significant difference between the patients with and without complications regarding gender and age (P = 0.206 and P = 0.824, respectively). Also, no significant difference was found between the two groups concerning the ejection fraction (P = 0.271). Lead fracture was the most frequent lead-related complication and was observed in 17 patients (6.6%). Besides, it was mainly observed in the RV leads. Generator-related complications leading to generator replacement were observed in 2 patients (0.7%).
CONCLUSIONS: Despite considerable improvements in the ICD technology, the rate of the ICD complications leading to device replacement and surgical revision, especially those related to the leads, is still clinically important.

Entities:  

Keywords:  Complication; Implantable Cardioverter Defibrillators; Implanted Electrodes

Year:  2014        PMID: 24936484      PMCID: PMC4058487     

Source DB:  PubMed          Journal:  Int Cardiovasc Res J        ISSN: 2251-9130


  24 in total

1.  Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories.

Authors:  Paul A Gould; Andrew D Krahn
Journal:  JAMA       Date:  2006-04-26       Impact factor: 56.272

2.  Complications associated with revision of Sprint Fidelis leads: report from the Canadian Heart Rhythm Society Device Advisory Committee.

Authors:  Ratika Parkash; Eugene Crystal; Jamil Bashir; Christopher Simpson; David Birnie; Laurence Sterns; Derek Exner; Bernard Thibault; Sean Connors; Jeffrey S Healey; Jean Champagne; Doug Cameron; Iqwal Mangat; Atul Verma; Kevin Wolfe; Vidal Essebag; Teresa Kus; Felix Ayala-Paredes; Ted Davies; Shubhayan Sanatani; Robert Gow; Benoit Coutu; Soori Sivakumaran; Elizabeth Stephenson; Andrew Krahn
Journal:  Circulation       Date:  2010-05-24       Impact factor: 29.690

3.  Performance and survival of transvenous defibrillation leads: need for a European data registry.

Authors:  Andreas Goette; Francesco Cantu; Lieselot van Erven; Peter Geelen; Franck Halimi; Jose L Merino; John M Morgan
Journal:  Europace       Date:  2008-11-11       Impact factor: 5.214

4.  Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients.

Authors:  Peter Alter; Stefan Waldhans; Eveline Plachta; Rainer Moosdorf; Wolfram Grimm
Journal:  Pacing Clin Electrophysiol       Date:  2005-09       Impact factor: 1.976

5.  The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators.

Authors:  Matthew R Reynolds; David J Cohen; Aaron D Kugelmass; Phillip P Brown; Edmund R Becker; Steven D Culler; April W Simon
Journal:  J Am Coll Cardiol       Date:  2006-05-30       Impact factor: 24.094

6.  Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.

Authors:  S J Connolly; M Gent; R S Roberts; P Dorian; D Roy; R S Sheldon; L B Mitchell; M S Green; G J Klein; B O'Brien
Journal:  Circulation       Date:  2000-03-21       Impact factor: 29.690

7.  Outcomes of elderly recipients of implantable cardioverter defibrillators.

Authors:  Wolfram Grimm; Astrid Stula; Julia Sharkova; Peter Alter; Bernhard Maisch
Journal:  Pacing Clin Electrophysiol       Date:  2007-01       Impact factor: 1.976

Review 8.  ICD leads: design and chronic dysfunctions.

Authors:  Rainer Gradaus; Günter Breithardt; Dirk Böcker
Journal:  Pacing Clin Electrophysiol       Date:  2003-02       Impact factor: 1.976

9.  Complications leading to surgical revision in implantable cardioverter defibrillator patients: comparison of patients with single-chamber, dual-chamber, and biventricular devices.

Authors:  Gabor Z Duray; Joern Schmitt; Sule Cicek-Hartvig; Stefan H Hohnloser; Carsten W Israel
Journal:  Europace       Date:  2008-12-02       Impact factor: 5.214

10.  Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead.

Authors:  Robert G Hauser; Linda M Kallinen; Adrian K Almquist; Charles C Gornick; William T Katsiyiannis
Journal:  Heart Rhythm       Date:  2007-04-10       Impact factor: 6.343

View more
  3 in total

1.  Efficacy of ultrasound-guided axillary/subclavian venous approaches for pacemaker and defibrillator lead implantation: a randomized study.

Authors:  Mattia Liccardo; Pasquale Nocerino; Salzano Gaia; Carmine Ciardiello
Journal:  J Interv Card Electrophysiol       Date:  2018-01-15       Impact factor: 1.900

2.  Repositioning a Displaced Right Ventricular Pacing Lead via Percutaneous Approach in Three Patients.

Authors:  Ahmad Yaminisharif; Seyed Hossein Ahmadi Tafti; Ali Hosseinsabet; Akbar Shafiee
Journal:  J Innov Card Rhythm Manag       Date:  2022-06-15

3.  Wideband LGE MRI permits unobstructed viewing of myocardial scarring in a patient with an MR-conditional subcutaneous implantable cardioverter-defibrillator.

Authors:  Amir Ali Rahsepar; Jeremy D Collins; Bradley P Knight; KyungPyo Hong; James C Carr; Daniel Kim
Journal:  Clin Imaging       Date:  2018-05-04       Impact factor: 1.605

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.